AlzeCure presents at Redeye Growth Day on June 2

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, today announced that the company will participate at Redeye Growth Day on June 2, 2021 at 10:20 CEST, where CEO Martin Jönsson will present the latest development in the company.

Watch the livestream via, where the presentation also will be available afterwards. The presentation will also be available afterwards on AlzeCure's company page at and on AlzeCure's website